부산대학교 도서관

Transcatheter aortic valve implantation (TAVI) performed using femoral arterial access is now a guideline recommended treatment for severe calcific aortic stenosis (AS) in elderly patients. Technological advancements and procedural refinements have focused on making TAVI simpler, safer, more effective and durable. Myval (Meril Lifesciences) is a new generation balloon-expandable transcatheter heart valve (THV) developed in India that possesses novel features to improve deliverability and aid precise deployment. Following the first-in-human study, Myval was approved in India for commercial implantation in October 2018 and was subsequently given a CE mark in April 2019. This article reviews thescience, technology and up-to-date clinical evidence for the Myval THV. Keywords Transcatheter heart valve, transcatheter aortic valve replacement, transcatheter aortic valve implantation, balloon expandable, Myval, aortic stenosis
Transcatheter aortic valve implantation (TAVI) via femoral arterial access has become the treatment of choice for elderly patients with severe calcific aortic stenosis (AS) who are at intermediate or high [...]